Correction to: Inflammation (2018) 41(2): 390-399
The original version of this article contained mistakes, and the authors would like to correct them. The correct details are given below:
• Fig. 4 A. In the GPO group, the S-O and H-E staining pictures were used incorrectly. This is our mistake.
The addition of GPO reduced the cartilage destruction in the OA ratmodel, assayed by Safranin-O staining, as well as H&E staining (a). Rat received intraperitoneal injections of GPO or vehicle (DMSO) during the fourth week after surgery. The OARSI score was calculated for each group (b). Values are mean ± SD. Significant differences from the control group are indicated by * P < 0.05. Significant differences from the OA group are indicated by # P < 0.05.
• Fig. 4 B. The name of the GPO drug treatment group is wrong, and the correct name should be OA+GPO.
The correct figure 4 can be seen at the next page.
The authors apologize for potential issues raised by these mistakes.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at https://doi.org/10.1007/s10753-017-0694-2
Rights and permissions
About this article
Cite this article
Pan, T., Shi, X., Chen, H. et al. Correction to: Geniposide Suppresses Interleukin-1β-Induced Inflammation and Apoptosis in Rat Chondrocytes via the PI3K/Akt/NF-κB Signaling Pathway. Inflammation 42, 404–405 (2019). https://doi.org/10.1007/s10753-018-0897-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-018-0897-1